Back to search
FDAFDA · Food and drugs·Recall number D-1104-2019

PAPAVERINE-PHENTOLAMINE-PGE1 17.64-0.58MG-5.88MCG/ML* INJECTABLE, 9 ml, Professional Compounding Pharmacy, 996 NW Circle Blvd. #105 Corvallis, OR 97330 .

Published April 17, 2019 · Recall initiated: February 21, 2019

Summary

FDA records drug Class II recall D-1104-2019, published April 17, 2019 and initiated February 21, 2019. Recalling firm: Health Solutions Pharmacy Center Inc dba Professional Compounding Pharmacy; Status: Terminated; Reported quantity: 1 prescription 9ml injection; Lot: Lot:17012019@18, distributed between 09-01-2018 to 02-20-2019. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Lack of Processing Controls: Insanitary conditions observed during compounding of sterile drugs during recent FDA Inspection.

What to do

Voluntary: Firm initiated · Telephone

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Health Solutions Pharmacy Center Inc dba Professional Compounding Pharmacy
Distributor
Dispensed in Oregon
Lot
Lot:17012019@18, distributed between 09-01-2018 to 02-20-2019.
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was PAPAVERINE-PHENTOLAMINE-PGE1 17.64-0.58MG-5.88MCG/ML* INJECTABLE, 9 ml, Professional Compounding Pharmacy, 996 NW Circle Blvd. #105 Corvallis, OR 97330 . recalled?

Yes. FDA published recall D-1104-2019 on April 17, 2019. Reported hazard: Lack of Processing Controls: Insanitary conditions observed during compounding of sterile drugs during recent FDA Inspection.

What should I do if I have this product?

Voluntary: Firm initiated · Telephone